O-GlcNAc cycling: implications for neurodegenerative disorders.
about
Elevated O-GlcNAc-dependent signaling through inducible mOGT expression selectively triggers apoptosisThree Decades of Research on O-GlcNAcylation - A Major Nutrient Sensor That Regulates Signaling, Transcription and Cellular MetabolismMitochondrial trafficking in neuronsIncreasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L miceAberrant O-GlcNAcylation disrupts GNE enzyme activity in GNE myopathy.Memory and synaptic plasticity are impaired by dysregulated hippocampal O-GlcNAcylation.O-GlcNAc-ylation in the Nuclear Pore Complex.O-GlcNAc cycling: emerging roles in development and epigenetics.Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B.Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic BehaviorVersatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.Gene expression of O-GlcNAc cycling enzymes in human breast cancersElevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signalingDisruption of Golgi morphology and altered protein glycosylation in PLA2G6-associated neurodegenerationMetabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners.Hsp90 regulates O-linked β-N-acetylglucosamine transferase: a novel mechanism of modulation of protein O-linked β-N-acetylglucosamine modification in endothelial cells.Undetectable histone O-GlcNAcylation in mammalian cellsRetinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy.Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.O-GlcNAc cycling shows neuroprotective potential in C. elegans models of neurodegenerative diseaseSpliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway.System-based proteomic and metabonomic analysis of the Df(16)A+/- mouse identifies potential miR-185 targets and molecular pathway alterationsModulation of transcription factor function by O-GlcNAc modification.Microarray discovery of new OGT substrates: the medulloblastoma oncogene OTX2 is O-GlcNAcylated.O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway.Chitin research revisited.O-GlcNAc profiling: from proteins to proteomes.Chemical tools to explore nutrient-driven O-GlcNAc cycling.Altered expression of O-GlcNAc-modified proteins in a mouse model whose glycemic status is controlled by a low carbohydrate ketogenic diet.The Utilities of Chemical Reactions and Molecular Tools for O-GlcNAc Proteomic Studies.Direct evidence of O-GlcNAcylation in the apicomplexan Toxoplasma gondii: a biochemical and bioinformatic study.Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy.O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.O-GlcNAcylation enhances anaplastic thyroid carcinoma malignancy.O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability.O-GlcNAc Transferase Is Essential for Sensory Neuron Survival and Maintenance.O-GlcNAcylation as a novel ammonia-induced posttranslational protein modification in cultured rat astrocytes.Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy.
P2860
Q24299073-63F2C637-9A6B-42A6-98A9-B9013BCBFC25Q26853027-E7E2A21F-640B-489E-9AA7-3A8BD555E263Q28291981-8F7B9F34-07EE-43AF-B397-4C350B569B8BQ28537913-CF7504E8-394C-4066-8325-58E490ACA2A7Q30315345-9C438B98-B403-475F-8FF3-FDC07C4A255EQ30843650-3A15A1D2-2E9D-4662-A947-A316C7E79A98Q33810805-B4F9A9A5-4A3D-4682-B6DE-66734358E5DDQ34049939-A09D6CF7-475D-4194-AB0C-F70CA2F4D0D2Q34077919-875F573C-BA7D-4F4F-ABEA-61B41EB935F4Q34188749-EAB717E1-4471-4383-8145-AF6CE138E283Q34434068-CB1D88DA-165F-4299-A1FB-CA093FAF1349Q34598611-2550EB0C-EC19-456C-98B9-956C2CA688F2Q35809895-E3651731-6FCA-4655-938F-3F94C98D70F6Q35828619-EC90238C-880B-480D-86A4-4909C3A62394Q35868876-7A9E0D4D-0E83-4174-A662-5EE40CBB99E3Q35882360-AEE402A9-0B27-427B-8F4D-A32A317313FCQ36041929-513C32E9-0314-4DD1-BE01-8AA3F8FD5111Q36213044-262AC401-7CDB-4099-87A6-D77DBA718765Q36890350-7F64C6EC-2AA5-4915-B402-607B345AB184Q37130046-7842D19E-7EA3-4FAB-9C50-0E367D60B4DFQ37568290-04B56E45-6087-4ED5-B3AD-24FC65CC0442Q37648367-DB80129B-C34B-4AB5-AC4F-594E33CFA506Q37660911-1BAECE3D-A4C0-49E1-9701-D4D40A23E0ACQ37702525-E7C7D210-2405-4F63-852F-56EDC1DEAF00Q37706003-499408E5-1F6D-4C97-B398-B629F53A05B1Q37720173-8DBB7221-3F7F-4155-ACA8-85491CF8207BQ37780452-DA63C46A-0157-4420-A7E9-3AD185230635Q38193224-D5B7484C-196E-457B-9642-5177E015DCB5Q38231368-5DE86EBC-60B8-4A22-8B02-2C064EE9B72AQ38314633-1C793EBC-CDE7-4888-AF4D-C082A10C7508Q38533861-1EE9F485-F26E-4E92-9636-4F34DB62F875Q39675387-DE72C35A-9FD6-4884-B135-971B3905DF92Q41321787-E8142035-1ADB-4223-8591-42A6B6938D73Q41782923-D7C9A18A-7662-4815-8765-8EA0CBBA1BCEQ41818529-D2F40CA5-2464-4760-B380-4600265E0196Q42007526-71AEE77B-4C53-47E4-90C0-4A6E9EE0B528Q42076002-0706809A-9292-4BFB-B5D6-9504D3471821Q42318087-9638E03A-674D-4BC3-83D5-A8BFA88A99D2Q44919170-61270826-853D-4E16-8743-F9388919F793Q47117481-3F98B118-21C2-46E0-AC5E-DDD36F11C21D
P2860
O-GlcNAc cycling: implications for neurodegenerative disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
O-GlcNAc cycling: implications for neurodegenerative disorders.
@en
O-GlcNAc cycling: implications for neurodegenerative disorders.
@nl
type
label
O-GlcNAc cycling: implications for neurodegenerative disorders.
@en
O-GlcNAc cycling: implications for neurodegenerative disorders.
@nl
prefLabel
O-GlcNAc cycling: implications for neurodegenerative disorders.
@en
O-GlcNAc cycling: implications for neurodegenerative disorders.
@nl
P2093
P2860
P1476
O-GlcNAc cycling: implications for neurodegenerative disorders.
@en
P2093
Brooke D Lazarus
Dona C Love
John A Hanover
P2860
P304
P356
10.1016/J.BIOCEL.2009.03.008
P577
2009-03-27T00:00:00Z